Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 21,958 | 17,548 | 8,071 | 26,837 | 23,562 |
| Gross Profit | 21,958 | 17,548 | 8,071 | 26,837 | 23,562 |
| Operating Expenses | 51,206 | 51,052 | 51,968 | 47,609 | 39,803 |
| Operating Income | -29,248 | -33,504 | -43,897 | -20,772 | -16,241 |
| Other Income | 1,887 | 3,148 | 1,694 | 1,553 | 3,398 |
| Pre-tax Income | -27,361 | -30,356 | -42,203 | -19,219 | -12,843 |
| Net Income Continuous | -27,361 | -30,356 | -42,203 | -19,219 | -12,843 |
| Minority Interests | -54 | -72 | -53 | N/A | N/A |
| Net Income | $-27,307 | $-30,284 | $-42,150 | $-18,664 | $-12,843 |
| EPS Basic Total Ops | -0.24 | -0.26 | -0.41 | -0.17 | -0.13 |
| EPS Basic Continuous Ops | -0.24 | -0.27 | -0.41 | -0.18 | -0.13 |
| EPS Diluted Total Ops | -0.24 | -0.26 | -0.41 | -0.17 | -0.13 |
| EPS Diluted Continuous Ops | -0.24 | -0.27 | -0.41 | -0.18 | -0.13 |
| EBITDA(a) | $-27,476 | $-32,712 | $-43,638 | $-21,867 | $-18,167 |